News
Obecure tests vertigo drug for obesity - UPI.com
www.upi.com
24 Jan — "There is a great unmet need for a safe and effective therapy that can control weight," said Yaffa Beck, chief executive officer of Obecure. › Health_News › › O...
D-Pharm und Nycomed Amersham Imaging begründen ...
www.ots.at
21 Nov — Dr. Yaffa Beck, Executive VP und COO, D-Pharm Ltd. Tel.: + , Fax: + , oder Mr. Albert ... › presseaussendung
Women In Technology International (WITI) Newsletter
witi.com
Dr. Yaffa Beck named Presidend and CEO of Israeli Bio-tech firm. Dr. Yaffa Beck has been named President and Chief Executive Officer of BrainStorm Cell ... › newsletter-archive
Now a 'wonder' drug for safer weight loss - Times of Indiatimesofindia.indiatimes.com › ... › Health & Fitness
timesofindia.indiatimes.com
... support the potential of the drug as a breakthrough anti-obesity agent in women 50 years old or less," Dr Yaffa Beck, Obecure's CEO said.
sorted by relevance / date